Current views on the management of atherosclerotic renovascular disease

References

• Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull. 2005;73–74: 35–55.
   Google Scholar
• Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, . Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443–51.
   PubMed Web of Science ®Google Scholar
• Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen S-C, . Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293–301.
   PubMed Web of Science ®Google Scholar
• Jazrawi A, Darda S, Burke P, Daccarett M, Stehlik J, David S, . Is race a risk factor for the development of renal artery stenosis? Cardiol Res Pract. 2009;2009:817987.
   PubMedGoogle Scholar
• Khosla S, Kunjummen B, Manda R, Khaleel R, Kular R, Gladson M, . Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography. Cathet Cardiovasc Intervent. 2003;58:400–3.
   PubMedGoogle Scholar
• MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998;352:13–16.
   PubMed Web of Science ®Google Scholar
• Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51N.
   PubMed Web of Science ®Google Scholar
• Kalra PA, Guo H, Gilbertson DT, Liu J, Chen S-C, Ishani A, . Atherosclerotic renovascular disease in the United States. Kidney Int. 2009;77:37–43.
   Google Scholar
• Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, . Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. 2010;55: A6–7.
   Google Scholar
• Shurrab AE, Mamtora H, O'Donoghue D, Waldek S, Kalra PA. Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease. Br J Radiol. 2001;74:213–8.
   PubMedGoogle Scholar
• Scoble JE, de Takats D, Ostermann ME, Connolly JO, Scott NR, Beeso JA, . Lipid profiles in patients with atherosclerotic renal artery stenosis. Nephron. 1999;83:117–21.
   PubMed Web of Science ®Google Scholar
• de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009;27:1333–40.
   PubMed Web of Science ®Google Scholar
• Keddis M, Garovic V, Bailey K, Wood CM, Raissian Y, Grande JP. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant. 2010;25:3615–22.
   PubMedGoogle Scholar
• Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994;344:237–9.
   PubMedGoogle Scholar
• Börgel J, Springer S, Ghafoor J, Arndt D, Duchna H-W, Barthel A, . Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol. 2010;99:499–506.
   PubMedGoogle Scholar
• Green D, Kalra PA. The heart in atherosclerotic renovascular disease. Front Biosci (Elite Ed). 2012;4:856–64.PMID 22201919
   PubMedGoogle Scholar
• Guazzi M, Brambilla R, Agostoni P, Guazzi MD. Influence of ACE-inhibition on salt-mediated worsening of pulmonary gas exchange in heart failure. Br J Clin Pharmacol. 2001;51: 482–7.
   PubMedGoogle Scholar
• de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective. J Am Soc Nephrol. 2003;14:2421–7.
   PubMedGoogle Scholar
• Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension. 1993;22:876–83.
   PubMed Web of Science ®Google Scholar
• Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, . Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol. 2002;13:149–57.
   PubMed Web of Science ®Google Scholar
• Dwyer KM, Vrazas JI, Lodge RS, Humphery TJ, Schlicht SM, Murphy BF, . Treatment of acute renal failure caused by renal artery occlusion with renal artery angioplasty. Am J Kidney Dis. 2002;40:189–94.
   PubMed Web of Science ®Google Scholar
• Chrysochou C, Sinha S, Chalmers N, Kalra PR, Kalra PA. Anuric acute renal failure and pulmonary oedema: a case for urgent action. Int J Cardiol. 2009;132:e31–3.
   Web of Science ®Google Scholar
• Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, . Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J. 2008;156: 549–55.
   PubMed Web of Science ®Google Scholar
• Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27:1403–9.
   PubMed Web of Science ®Google Scholar
• ; ASTRAL InvestigatorsWheatley K, Ives N, Gray R, Kalra PA, Moss JG, . Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361: 1953–62.
   PubMed Web of Science ®Google Scholar
• Wright J, Shurrab A, Cheung C, Waldek S, O'Donoghue D, Foley R, . A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis. 2002;39:1153–61.
   PubMed Web of Science ®Google Scholar
• Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM. 2009;102: 695–704.
   PubMedGoogle Scholar
• Suresh M, Laboi P, Mamtora H, Kalra PA. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant. 2000;15:631–6.
   PubMedGoogle Scholar
• Textor SC. Renovascular hypertension in 2007: where are we now? Curr Cardiol Rep. 2007;9:453–61.
   PubMedGoogle Scholar
• Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis. 2009;52:184–95.
   PubMed Web of Science ®Google Scholar
• Chrysochou C, Cheung CM, Durow M, Middleton RJ, Solomon LR, Craig A, . Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD). QJM. 2009;102:283–8.
   PubMed Web of Science ®Google Scholar
• Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension. 2005;45:1042–9.
   PubMed Web of Science ®Google Scholar
• Meier P. Atherosclerotic renal artery stenosis: update on management strategies. Curr Opin Cardiol. 2011;26:463–71.
   PubMedGoogle Scholar
• Amighi J, Schlager O, Haumer M, Dick P, Mlekusch W, Loewe C, . Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. Eur J Clin Invest. 2009;39:784–92.
   PubMedGoogle Scholar
• Conlon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, . Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252–6.
   PubMed Web of Science ®Google Scholar
• Hansen KJ, Tribble RW, Reavis SW, Canzanello VJ, Craven TE, Plonk GW, . Renal duplex sonography: evaluation of clinical utility. J Vasc Surg. 1990;12:227–36.
   PubMed Web of Science ®Google Scholar
• Kohler TR, Zierler RE, Martin RL, Nicholls SC, Bergelin RO, Kazmers A, . Noninvasive diagnosis of renal artery stenosis by ultrasonic duplex scanning. J Vasc Surg. 1986;4: 450–6.
   PubMed Web of Science ®Google Scholar
• Rountas C, Vlychou M, Vassiou K, Liakopoulos V, Kapsalaki E, Koukoulis G, . Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail. 2007;29:295–302.
   PubMed Web of Science ®Google Scholar
• Kiefer C, Schroth G, Gralla J, Diehm N, Baumgartner I, Husmann M. A feasibility study on model-based evaluation of kidney perfusion measured by means of FAIR prepared true-FISP arterial spin labeling (ASL) on a 3-T MR scanner. Acad Radiol. 2009;16:79–87.
   PubMedGoogle Scholar
• Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, . The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol. 2008;19:780–8.
   PubMed Web of Science ®Google Scholar
• Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, . Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension. 2010;55: 961–6.
   PubMed Web of Science ®Google Scholar
• Chrysochou C, Mendichovszky IA, Buckley DL, Cheung CM, Jackson A, Kalra PA. BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27:1013–9.
   PubMed Web of Science ®Google Scholar
• Warner L, Glockner JF, Woollard J, Textor SC, Romero JC, Lerman LO. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol. 2011;46:41–7.
   PubMedGoogle Scholar
• Cooper C, Murphy T, Matsumoto A, Steffes M, Cohen D, Jaff M, . Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial. Am Heart J. 2006;152:59–66.
   PubMed Web of Science ®Google Scholar
• Colyer WR, Cooper CJ. Management of renal artery stenosis: 2010. Curr Treat Options Cardiovasc Med. 2011;13: 103–13.
   PubMedGoogle Scholar
• Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg. 2005;41:1026–30.
   PubMedGoogle Scholar
• Kanjwal K, Cooper CJ, Virmani R, Haller S, Shapiro JI, Burket MW, . Predictors of embolization during protected renal artery angioplasty and stenting: role of antiplatelet therapy. Cathet Cardiovasc Intervent. 2010;76:16–23.
   PubMedGoogle Scholar
• Haller S, Adlakha S, Reed G, Brewster P, Kennedy D, Burket MW, . Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization. Clin J Am Soc Nephrol. 2011;6:2185–91.
   PubMedGoogle Scholar
• Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, . Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117: 2752–60.
   PubMed Web of Science ®Google Scholar
• Shah S, Paparello J, Danesh FR. Effects of statin therapy on the progression of chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:187–95.
   PubMedGoogle Scholar
• Huskey J, Lindenfeld J, Cook T, Targher G, Kendrick J, Kjekshus J, . Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S). Atherosclerosis. 2009;205:202–6.
   PubMed Web of Science ®Google Scholar
• Baigent C, Landray M, Reith C, Emberson J, Wheeler DC, Tomson C, . The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377: 2181–92.
   PubMed Web of Science ®Google Scholar
• Bates MC, Campbell JE, Stone PA, Jaff MR, Broce M, Lavigne PS. Factors affecting long-term survival following renal artery stenting. Cathet Cardiovasc Intervent. 2007;69: 1037–43.
   PubMedGoogle Scholar
• Silva VS, Martin LC, Franco RJS, Carvalho FC, Bregagnollo EA, Castro JH, . Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens. 2008;21:1163–8.
   PubMedGoogle Scholar
• Cheung CM, Patel A, Shaheen N, Cain S, Eddington H, Hegarty J, . The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107:c35–42.
   Google Scholar
• Chade AR, Zhu X-Y, Grande JP, Krier JD, Lerman A, Lerman LO. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens. 2008;26: 1651–60.
   PubMedGoogle Scholar
• Agarwal R. Blood pressure goal in chronic kidney disease: what is the evidence? Curr Opin Nephrol Hypertens. 2011;20:229–32.
   PubMedGoogle Scholar
• Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, . Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.
   PubMed Web of Science ®Google Scholar
• Franklin SS, Smith RD. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med. 1985;79:14–23.
   PubMed Web of Science ®Google Scholar
• Burke TA, Sturkenboom MC, Lu S-E, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006;24:1193–200.
   PubMed Web of Science ®Google Scholar
• Bart BA, Gattis WA, Diem SJ, O'Connor CM. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol. 1997;79:1118–20.
   PubMedGoogle Scholar
• Losito A. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005;20:1604–9.
   PubMed Web of Science ®Google Scholar
• van de Ven PJ, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Koomans HA. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998;53:986–93.
   PubMed Web of Science ®Google Scholar
• Hackam DG, Spence JD, Garg AX, Textor SC. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension. 2007;50:998–1003.
   PubMed Web of Science ®Google Scholar
• Singer GM, Izhar M, Black HR. Goal-oriented hypertension management: translating clinical trials to practice. Hypertension. 2002;40:464–9.
   PubMed Web of Science ®Google Scholar
• Faselis C, Doumas M, Papademetriou V. Common secondary causes of resistant hypertension and rational for treatment. Int J Hypertens. 2011;2011:236239.
   PubMedGoogle Scholar
• Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, . Increased sympathetic nerve activity in renovascular hypertension. Circulation. 1999;99:2537–42.
   PubMed Web of Science ®Google Scholar
• Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999; 17(Pt 1):1743–50.
   PubMedGoogle Scholar
• Cianci R, Martina P, Borghesi F, di Donato D, Polidori L, Lai S, . Revascularization versus medical therapy for renal artery stenosis: antihypertensive drugs and renal outcome. Angiology. 2011;62:92–9.
   PubMedGoogle Scholar
• Duranay M, Kanbay M, Akay H, Unverdi S, Sürer H, Altay M, . Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: a pilot study. Nephron Clin Pract. 2010;114:c213–7.
   PubMedGoogle Scholar
• Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, . Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation. 2009;119:547–57.
   PubMed Web of Science ®Google Scholar
• Chade AR, Zhu X-Y, Krier JD, Jordan KL, Textor SC, Grande JP, . Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells. 2010;28:1039–47.
   PubMedGoogle Scholar
• Kelsen S, Hall JE, Chade AR. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease. Am J Physiol Renal Physiol. 2011;301: F218–25.
   PubMed Web of Science ®Google Scholar
• Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65:2003–17.
   PubMed Web of Science ®Google Scholar
• Iliescu R, Fernandez SR, Kelsen S, Maric C, Chade AR. Role of renal microcirculation in experimental renovascular disease. Nephrol Dial Transplant. 2010;25:1079–87.
   PubMed Web of Science ®Google Scholar
• Chade AR, Kelsen S. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease. Circ Cardiovasc Interv. 2010;3:376–83.
   PubMed Web of Science ®Google Scholar
• Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, . Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329–35.
   PubMed Web of Science ®Google Scholar
• Plouin PF, Chatellier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823–9.
   PubMed Web of Science ®Google Scholar
• van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, . The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007–14.
   PubMed Web of Science ®Google Scholar
• Bax L, Woittiez A-JJ, Kouwenberg HJ, Mali WPTM, Buskens E, Beek FJA, . Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150:840–8, W150–1.
   PubMed Web of Science ®Google Scholar
• Dorros G, Prince C, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn. 1993;29:191–8.
   PubMedGoogle Scholar
• Rundback JH, Manoni T, Rozenblit GN, Poplausky M, Maddineni S, Crea G, . Balloon angioplasty or stent placement in patients with azotemic renovascular disease: a retrospective comparison of clinical outcomes. Heart Dis. 1999;1:121–5.
   PubMedGoogle Scholar
• Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142: 314–23.
   PubMed Web of Science ®Google Scholar
• Kumbhani DJ, Bavry AA, Harvey JE, de Souza R, Scarpioni R, Bhatt DL, . Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J. 2011;161:622–30.e1.
   PubMedGoogle Scholar
• Khosla S, Ahmed A, Siddiqui M, Trivedi A, Benatar D, Salem Y, . Safety of angiotensin-converting enzyme inhibitors in patients with bilateral renal artery stenosis following successful renal artery stent revascularization. Am J Ther. 2006;13:306–8.
   PubMedGoogle Scholar
• Subramanian R, White CJ, Rosenfield K, Bashir R, Almagor Y, Meerkin D, . Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc Interv. 2005;64:480–6.
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, . ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)—summary of recommendations. J Vasc Interv Radiol. 2006;17:1383–97; quiz 1398.
   PubMed Web of Science ®Google Scholar
• Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2010;25:813–20.
   PubMed Web of Science ®Google Scholar
• Hegde U, Rajapurkar M, Gang S, Khanapet M, Durugkar S, Gohel K, . Fifteen years’ experience of treating atherosclerotic renal artery stenosis by interventional nephrologists in India. Semin Dial. 2012;25:97–104.
   PubMedGoogle Scholar
• Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, . The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Cathet Cardiovasc Intervent. 2010;75: 1–10.
   PubMedGoogle Scholar
• Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J, . Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78–85.
   PubMed Web of Science ®Google Scholar
• Corriere MA, Edwards MS, Pearce JD, Andrews JS, Geary RL, Hansen KJ. Restenosis after renal artery angioplasty and stenting: incidence and risk factors. J Vasc Surg. 2009;50: 813–9.e1.
   PubMedGoogle Scholar
• Kiernan TJ, Yan BP, Eisenberg JD, Ruggiero NJ, Gupta V, Drachman D, . Treatment of renal artery in-stent restenosis with sirolimus-eluting stents. Vasc Med. 2010;15:3–7.
   PubMedGoogle Scholar
• Zähringer M, Sapoval M, Pattynama PMT, Rabbia C, Vignali C, Maleux G, . Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther. 2007;14:460–8.
   PubMedGoogle Scholar
• Silva JA, Chan AW, White CJ, Collins TJ, Jenkins JS, Reilly JP, . Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111:328–33.
   PubMed Web of Science ®Google Scholar
• Staub D, Zeller T, Trenk D, Maushart C, Uthoff H, Breidthardt T, . Use of B-type natriuretic peptide to predict blood pressure improvement after percutaneous revascularisation for renal artery stenosis. Eur J Vasc Endovasc Surg. 2010;40:599–607.
   PubMedGoogle Scholar
• Friberg P, Meredith I, Jennings G, Lambert G, Fazio V, Esler M. Evidence for increased renal norepinephrine overflow during sodium restriction in humans. Hypertension. 1990;16: 121–30.
   PubMed Web of Science ®Google Scholar
• Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res. 1991;1:187–94.
   PubMedGoogle Scholar
• Kaye D, Esler M, Kingwell B, McPherson G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation. 1993;88:1110–8.
   PubMed Web of Science ®Google Scholar
• Esler MD, Nestel PJ. Sympathetic responsiveness to head-up tilt in essential hypertension. Clin Sci. 1973;44:213–26.
   PubMed Web of Science ®Google Scholar
• Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, . Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.
   PubMed Web of Science ®Google Scholar
• Simonetti G, Spinelli A, Gandini R, Da Ros V, Gaspari E, Coco I, . Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience. Radiol Med. 2012;117:426–44.
   PubMedGoogle Scholar
• , Symplicity HTN-2 InvestigatorsEsler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.
   PubMed Web of Science ®Google Scholar
• DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245–53.
   PubMed Web of Science ®Google Scholar